Macular health · Patient guide

Dry Macular Degeneration: What Helps and What Doesn't

Dry age-related macular degeneration needs stage-specific care, not a universal eye-vitamin prescription. Understand monitoring, supplements, practical support and the changes that should bring your next assessment forward.

Quick answer: Dry AMD affects the macula, which provides detailed central vision. Care depends on the stage and may include monitoring, smoking cessation, selected AREDS2 supplements and low-vision support. Some advanced cases may warrant discussion of newer therapies. New distortion or a central dark patch needs prompt assessment for wet AMD or another cause.

What is dry macular degeneration?

The macula is a small central part of the retina used for reading, recognising faces and seeing detail. Dry age-related macular degeneration involves age-related changes in this tissue and its supporting structures. Deposits called drusen and changes in pigmentation can be important findings.

“Dry” does not mean that the eye needs lubricating drops. Dry eye affects the eye surface and is a different condition. Artificial tears may help surface symptoms, but they do not rebuild damaged macular tissue.

The condition can differ between the eyes. Someone may notice little difficulty because the better eye compensates, so an absence of obvious blur is not enough to establish the stage.

Early, intermediate and advanced dry AMD

Early changes may cause no symptoms. Intermediate disease can still be subtle, though reading in dim light or adjusting to lower lighting may become harder. Advanced dry disease can involve areas of cell loss called geographic atrophy.

The stage is determined by the retinal findings, not simply by age or the strength of the glasses prescription. Not all early disease progresses quickly, and not everyone develops advanced loss in both eyes.

On a phone, swipe sideways to read the table.

Stage or findingCare discussionDo not assume
Early changesMonitoring, risk reduction and symptom awareness.Every patient needs high-dose supplements.
Intermediate AMDWhether AREDS2 is suitable and how to monitor.Vitamins restore already-lost central vision.
Geographic atrophyProgression, support needs and selected therapy discussions.All newer treatments are suitable or available locally.
New distortion or rapid changePrompt assessment for wet AMD or another cause.A previous dry diagnosis makes waiting safe.

Which symptoms can occur?

Symptoms can include central blur, difficulty recognising faces, needing more light for close work or a patch of reduced detail. In later disease, distortion or missing central areas can interfere with daily activities.

These symptoms are not unique to AMD. Cataract, other retinal diseases and optic-nerve problems may need consideration. An eye examination helps avoid incorrectly attributing every visual change to an old diagnosis.

New wavy lines, a dark central patch or a sudden change deserves prompt assessment. Do not assume that all change in a person with dry AMD must be slow or expected.

Risk factors and habits worth changing

Increasing age, smoking and family history are important risk factors. Some cannot be changed, but they can guide the discussion about monitoring and prevention.

Stopping smoking is a practical step. Ask for cessation support if needed. A balanced diet including leafy vegetables and other suitable nutrient-rich foods, regular activity appropriate to your health and management of cardiovascular risk are useful parts of overall care.

Follow advice for blood pressure and other medical conditions rather than changing medicines independently. Healthy habits support care, but no particular food, juice or exercise programme has been shown to reverse established retinal cell loss.

How is dry AMD diagnosed and monitored?

The clinician assesses symptoms, visual acuity and the retina, often using dilating drops. OCT can show macular layers and help assess changes, including whether fluid suggests another form of disease.

Photographs or other imaging may be useful for documenting progression or a specific question. The team decides what is needed; this article does not confirm an on-site test package or mandatory scan at every visit.

Ask for the stage in each eye, the next review date and the symptoms that should trigger an earlier appointment. Bring earlier reports where possible. Arrange safe transport if dilation or impaired vision affects driving.

When can AREDS2 supplements help?

AREDS2 refers to a studied combination of vitamins and minerals used for selected AMD stages. It may reduce progression risk in appropriate patients, including some with intermediate AMD or advanced disease in one eye.

It is not a general preventive tablet for every older adult, and it does not cure AMD or restore dead retinal cells. A routine multivitamin is not automatically equivalent. Ask whether your stage fits the evidence before buying a product.

Do not self-prescribe high-dose eye vitamins. Discuss all medicines and supplements with the clinician. Older beta-carotene-containing AREDS formulations can increase lung-cancer risk in people who smoke or used to smoke. Mention any smoking history and have the actual ingredients checked.

More is not necessarily better. Combining several products can duplicate high doses or cause interactions. This page deliberately does not prescribe a dose or brand. Supplements must not delay assessment of new distortion or replace treatment for active wet AMD.

Is there any treatment for advanced dry AMD?

It is too broad to say that no treatment exists anywhere. Selected geographic-atrophy treatments have been approved in the United States and can slow the enlargement of atrophic areas in some patients. They do not restore lost retinal tissue or guarantee improved vision.

These treatments can involve repeated eye injections, costs, monitoring and important risks, including inflammation, infection-related injection risks and development of wet AMD. Suitability requires a careful discussion of the expected benefit and treatment burden.

Overseas approval is not confirmation of approval, supply or availability in India or at this clinic. Ask the specialist what is currently appropriate and locally available for your exact stage. Do not import or arrange treatment based only on an advertisement.

Other new technologies and clinical trials also need individual scrutiny. Ask what evidence supports a claim, whether the use is approved and how potential harms will be monitored. A promotional description is not a guarantee of restored sight.

Home monitoring and the Amsler grid

An Amsler grid is a pattern of straight lines that can help a person notice central distortion. If your team recommends it, ask them to demonstrate the distance, lighting, reading correction and how to check each eye separately.

Report new waviness, missing squares or another meaningful change promptly. A normal grid does not exclude all disease, and it is not a substitute for scheduled retinal examinations. Avoid repeatedly testing instead of seeking help for a clear new symptom.

Keep a simple record of any change and when it started. If you cannot use the grid reliably because of existing vision loss, ask about another monitoring approach rather than assuming home checks are impossible.

Low-vision aids can help before vision becomes severe

Good task lighting, reduced glare, larger text, electronic magnification and device accessibility settings can make daily activities easier. A low-vision assessment helps match aids to the tasks that matter to you.

Ask for support with medicine labels, cooking, reading bills and safe mobility. Occupational or vision rehabilitation can teach practical strategies. Seeking these services is not an admission that treatment has failed.

Do not drive when vision is unsafe. Discuss visual requirements with the treating team and arrange alternatives when necessary. Family members can help with transport and appointments without taking over every activity.

Costs and questions for your next appointment

No clinic-confirmed price is given here. Ask what consultation, imaging, supplements if appropriate and any proposed specialist treatment would cost. Check continuing costs and follow-up needs rather than comparing only a first-visit fee.

Useful questions include: What stage is each eye? Does AREDS2 apply to me? Is geographic atrophy present? What change needs an urgent call? What practical support is available? Keep the written plan and the next review date.

When should you seek urgent help?

New distortion, central darkness or a rapid change needs prompt assessment, even with a previous dry-AMD diagnosis. Sudden marked sight loss, a curtain, new flashes or a shower of floaters needs urgent eye care. If timely clinic assessment is unavailable, use the nearest hospital emergency/casualty service. Routine clinic contact is not a confirmed 24-hour emergency line.

Frequently asked questions

Can dry AMD turn wet?

Yes. A previous dry-AMD diagnosis does not rule out later wet AMD. New wavy lines, central blur or a dark patch should be assessed promptly instead of waiting for a routine review.

Do supplements work?

AREDS2 supplements can reduce progression risk in selected AMD stages, but they do not cure the disease or restore lost vision. Ask whether your stage is eligible and review ingredients, smoking history and medicines before starting.

Is there a treatment for dry AMD?

Care depends on the stage and includes monitoring, risk reduction, selected supplements and low-vision support. Some geographic-atrophy therapies approved overseas can slow progression, not restore vision. Suitability and current local approval and availability must be confirmed with a specialist.

Ask for a stage-specific plan

Bring previous reports and a list of all supplements and medicines. Understand what needs monitoring and which new symptoms should bring you back sooner.

Further reading: National Eye Institute: AREDS2 supplements and American Academy of Ophthalmology: geographic-atrophy treatment considerations. General education, not a personal prescription or confirmation of local availability.